Ido Zairi

Ido Zairi is a seasoned finance professional with extensive experience in risk management and investment within the biotechnology sector. Since December 2014, Ido has served as a General Partner at Israel Biotech Fund, focusing on the growth of Israeli clinical-stage biotechnology companies. In addition to this role, Ido holds board positions at Splisense and Vensica Therapeutics, and is a Managing Director at Mendham Investment Group. Prior to these roles, Ido gained significant expertise as Managing Director and Head of Risk Management at Jefferies & Company, and as Director of Global Risk Management at Knight Trading Group. Ido's early career includes leadership positions in risk management at Arbitrade/Knight Financial Products and Arbitrade Holdings. Ido holds a BA in Economics from The Hebrew University of Jerusalem and participated in an Executive Education program at Harvard Business School.